Release Date: 27/02/17 08:44 Summary: Update on Form 20-F for Proposed Nasdaq Dual Listing Price Sensitive: No Download Document 160.04KB Download
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status